Table 3.
Results of Meta-analysis of diastolic blood pressure
Study | | SMD | [95% Conf. Interval] | % Weight | |
---|---|---|---|---|
Carter (1997) [8] | | 0.110 | −0.439 | 0.660 | 8.55 |
Carter (2009) [15] | | -0.108 | −0.304 | 0.087 | 18.74 |
Schumacher (2018) | | -0.654 | −0.884 | −0.424 | 17.58 |
Korcegez (2017) | | -0.584 | −0.908 | −0.259 | 14.37 |
Domingues (2017) [40] | | -0.285 | −0.715 | 0.144 | 11.27 |
Javaid (2019) [42] | | -0.402 | −0.752 | −0.052 | 13.57 |
Shao (2017) | | -0.203 | −0.482 | 0.075 | 15.91 |
D + L pooled SMD | | -0.329 | −0.532 | −0.125 | 100.00 |
Heterogeneity chi-squared =18.35 (d.f. = 6) p = 0.005.
I-squared (variation in SMD attributable to heterogeneity) = 67.3%.
Estimate of between-study variance Tau-squared = 0.0476.
Test of SMD = 0: z = 3.17 p = 0.002.
The significance level of the combined effect quantity test: 0.05.
The significance level of the heterogeneity test: 0.1.
Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.